Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction

NCT00203476 is registered in ClinicalTrials.gov with Tuscaloosa Research & Education Advancement Corporation as lead sponsor.

NCT NCT00203476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00203476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction
Lead sponsor
Tuscaloosa Research & Education Advancement Corporation
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2005
Completion date
January 31, 2008
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia, hyperlipidemia